Bank Julius Baer & Co’s InflaRx IFRX Stock Holding History

Bank Julius Baer & Co’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-197,607	Closed	-$941K	–	682
2021 Q4	$941K	Hold	197,607	–	–	0.01%	359
2021 Q3	$512K	Sell	197,607 -36	-0%	-$95	﹤0.01%	424
2021 Q2	$587K	Buy	+197,643	New	+$655K	﹤0.01%	428
2021 Q1	–	Sell	-197,614	Closed	-$994K	–	856
2020 Q4	$994K	Buy	+197,614	New	+$889K	0.01%	352

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Bank Julius Baer & Co's IFRX Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of InflaRx (IFRX) in Q1 2022, closing a stake of 197,607 shares — an estimated $941K sold.

Bank Julius Baer & Co first reported a position in IFRX in Q4 2020 and held it in 4 quarters. The position peaked at $994K in Q4 2020. 32 funds tracked by Wall St. Rank hold IFRX as of Q1 2022.

Bank Julius Baer & Co reported no remaining InflaRx position as of Q1 2022 after selling out during the quarter.
Bank Julius Baer & Co sold 197,607 InflaRx shares in Q1 2022, an estimated $941K.
Bank Julius Baer & Co first reported a position in InflaRx in Q4 2020 and held it in 4 quarters.
Bank Julius Baer & Co's InflaRx position peaked at $994K in Q4 2020.
32 funds tracked by Wall St. Rank held InflaRx as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.